Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting DNA Damage Response in Prostate and Breast Cancer. | Int J Mol Sci | 2020 | 33158305 | PubTator, text mining | PubMed |
| Conjoint analysis for hepatic carcinoma with hub genes and multi-slice spiral CT. | Medicine (Baltimore) | 2020 | 33157984 | PubTator, text mining | PubMed |
| Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge. | Front Oncol | 2020 | 33154944 | PubTator, text mining | PubMed |
| A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation. | Lancet Oncol | 2020 | 33152285 | PubTator, text mining | PubMed |
| Modified base-binding EVE and DCD domains: striking diversity of genomic contexts in prokaryotes and predicted involvement in a variety of cellular processes. | BMC Biol | 2020 | 33148243 | PubTator, text mining | PubMed |
| Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses. | Neoplasia | 2020 | 33142233 | PubTator, text mining | PubMed |
| The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer. | Front Oncol | 2020 | 33134168 | PubTator, text mining | PubMed |
| Evolutionarily Selected Overexpression of the Cytokine BAFF Enhances Mucosal Immune Response Against P. falciparum. | Front Immunol | 2020 | 33123155 | PubTator, text mining | PubMed |
| RTKN2 is Associated with Unfavorable Prognosis and Promotes Progression in Non-Small-Cell Lung Cancer. | Onco Targets Ther | 2020 | 33122912 | PubTator, text mining | PubMed |
| Identification and Validation of Novel Genes in Anaplastic Thyroid Carcinoma via Bioinformatics Analysis. | Cancer Manag Res | 2020 | 33116838 | PubTator, text mining | PubMed |
| MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation. | Cancer Manag Res | 2020 | 33116820 | PubTator, text mining | PubMed |
| Long Noncoding RNA CDKN2B-AS1 Facilitates Lung Cancer Development Through Regulating miR-378b/NR2C2. | Onco Targets Ther | 2020 | 33116641 | PubTator, text mining | PubMed |
| LncRNA MIR194-2HG Promotes Cell Proliferation and Metastasis via Regulation of miR-1207-5p/TCF19/Wnt/β-Catenin Signaling in Liver Cancer. | Onco Targets Ther | 2020 | 33116574 | PubTator, text mining | PubMed |
| Exploring the Complexity of Protein-Level Dosage Compensation that Fine-Tunes Stoichiometry of Multiprotein Complexes. | PLoS Genet | 2020 | 33112847 | PubTator, text mining | PubMed |
| Efavirenz induces DNA damage response pathway in lung cancer. | Oncotarget | 2020 | 33110481 | PubTator, text mining | PubMed |
| Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis. | Mol Ther Oncolytics | 2020 | 33102693 | PubTator, text mining | PubMed |
| Identification of DHX9 as a cell cycle regulated nucleolar recruitment factor for CIZ1. | Sci Rep | 2020 | 33093612 | PubTator, text mining | PubMed |
| Low E2F2 activity is associated with high genomic instability and PARPi resistance. | Sci Rep | 2020 | 33087787 | PubTator, text mining | PubMed |
| Development of synthetic lethality in cancer: molecular and cellular classification. | Signal Transduct Target Ther | 2020 | 33077733 | PubTator, text mining | PubMed |
| Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR. | Cancer Manag Res | 2020 | 33061598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=55